How has the intravenous infusion pumps market evolved, and where is it heading next?
The intravenous infusion pumps market size has grown strongly in recent years. It will grow from $5.99 billion in 2024 to $6.42 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to increasing neurological disorders, aging population, stroke awareness and diagnosis, multidisciplinary approach.
The intravenous infusion pumps market size is expected to see strong growth in the next few years. It will grow to $9.27 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to minimally invasive procedures, emerging markets growth, regulatory support and reimbursement, telehealth and remote consultation. Major trends in the forecast period include artificial intelligence (ai) and image analysis, robotics and navigation, patient-specific devices, hybrid operating rooms.
Get Your Free Sample of The Global Intravenous Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3305&type=smp
What are the key drivers behind the rapid expansion of the intravenous infusion pumps market?
The rise in the prevalence of chronic diseases is expected to propel the growth of the intravenous infusion pumps market. Intravenous infusion pumps are used to deliver pharmaceutical drugs during the treatment of these diseases. Chronic illnesses and disorders are on the rise around the world, which can be attributed to an aging population and shifts in social behavior that led to a gradual increase of these widespread and expensive long-term medical issues. Infusion pumps are used to transfer regulated doses of nutrients or drugs into a patient’s body, such as chemotherapy medicines, pain relievers, antibiotics, insulin, or other hormones. For instance, in March 2022, according to the Australian Bureau of Statistics, an Australia-based autonomous statutory agency tasked with obtaining and analyzing data and making factual recommendations to local, national, and territorial governments, almost fifty percent of the population (46.6%, or 11.6 million) suffered from at least one chronic illness. Therefore, the rise in the prevalence of chronic diseases is going to propel the growth of the intravenous infusion pumps market going forward.
What is the segmentation for the intravenous infusion pumps market?
The intravenous infusion pumps market covered in this report is segmented –
1) By Product: Volumetric, Syringe, Enteral, Ambulatory, IV Disposables, Other Products
2) By Application: Chemotherapy, Diabetes, Gastroenterology, Analgesia/Pain Management, Pediatrics/Neonatology, Hematology, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Cancer Treatment Centers, Specialty Clinics, Other End Users
Subsegments:
1) By Volumetric: Large-volume Pumps, Small-volume Pumps
2) By Syringe: Micro Syringe Pumps, Macro Syringe Pumps
3) By Enteral: Portable Enteral Pumps, Stationary Enteral Pumps
4) By Ambulatory: Patient-controlled Analgesia (PCA) Pumps, Insulin Pumps, Disposable Pumps
5) By IV Disposables: IV Tubing Sets, IV Catheters, IV Cannulas, IV Solutions
6) By Other Products: Implantable Pumps, Smart Pumps, Elastomeric Pumps
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Who are the most influential companies in the intravenous infusion pumps market?
Major companies operating in the intravenous infusion pumps market include B. Braun Melsungen AG, Baxter International Inc., Medtronic plc, Fresenius Kabi AG, Smiths Medical Inc., Becton Dickinson and Company (BD), Terumo Corporation, F. Hoffmann-La Roche Ltd., ICU Medical Inc., IRadimed Corporation, Mindray Medical International Limited, Zyno Medical LLC, Tandem Diabetes Care Inc., Johnson & Johnson, Micrel Medical Devices SA, Boston Scientific Corporation, Pfizer Inc., Q-Core Medical Ltd., Moog Inc., Roche Diagnostics International AG, Nipro Corporation, Animas Corporation, Ypsomed Holding AG, Valeritas Inc., ZOLL Medical Corporation, Codan Medical A/S, Halyard Health Inc., InfuSystem Holdings Inc., Hospira Infusion Systems, CareFusion Corporation
How will emerging trends drive the intravenous infusion pumps market throughout the forecast period?
The growing technological improvement is a major trend gaining popularity in the intravenous infusion pumps market. Technological advances in infusion pumps have changed medical care in hospitals and allowed patients to inject fluids on an outpatient basis or in a home setting, allowing them to seek treatment while living their daily lives, through the use of smart intravenous infusion pumps. These smart intravenous infusion pumps help prevent medication errors and reduce patient harm. Some of the major companies investing in smart intravenous pumps include Fresenius Kabi, Q-Core Medical, Becton Dickinson, Micrel Medical Devices, and Baxter International. In another instance, vTitan, a Chennai-based healthcare company, announced the launch of the next generation of Syringe Infusion Pumps, which are used for critical care in hospitals and homes for reliable and safe infusion of drugs.
How do regional factors impact the intravenous infusion pumps market, and which region is the largest contributor?
North America was the largest region in the intravenous infusion pumps market in 2023. Western Europe was the second-largest region in the intravenous infusion pumps market. The regions covered in the intravenous infusion pumps market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Intravenous Infusion Pumps Market Report 2025 Offer?
The intravenous infusion pumps market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Intravenous infusion pumps are devices designed to administer fluids, medications, or nutrients directly into a patient’s veins with accuracy and consistency, supporting effective treatment in critical and routine medical care.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3305
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
